Pictet Asset Management (UK)’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$14.3M Sell
50,484
-6,662
-12% -$1.81M 0.02% 598
2021
Q1
$12.1M Sell
57,146
-16,252
-22% -$3.89M 0.01% 618
2020
Q4
$14.4M Sell
73,398
-75,623
-51% -$13.4M 0.02% 550
2020
Q3
$24.5M Sell
149,021
-26,274
-15% -$4.33M 0.04% 398
2020
Q2
$24.3M Sell
175,295
-89,998
-34% -$8.26M 0.04% 368
2020
Q1
$16.6M Sell
265,293
-128,455
-33% -$11.7M 0.04% 404
2019
Q4
$43.1M Buy
393,748
+200
+0.1% +$19.4K 0.08% 297
2019
Q3
$40.8M Buy
393,548
+100,817
+34% +$10.8M 0.09% 261
2019
Q2
$37.6M Buy
292,731
+105,886
+57% +$14.7M 0.08% 283
2019
Q1
$23.8M Buy
+186,845
New +$23.7M 0.05% 367

Other funds holding MED

Pictet Asset Management (UK)'s MED Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Medifast (MED) stake by 12% in Q2 2021, selling an estimated $1.81M and leaving 50,484 shares worth $14.3M. The position accounts for 0.02% of the portfolio, ranked #598.

Pictet Asset Management (UK) first reported a position in MED in Q1 2019 and has held it in 10 quarters since. The position peaked at $43.1M in Q4 2019. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

  • Pictet Asset Management (UK) held 50,484 shares of Medifast worth $14.3M as of Q2 2021.
  • Pictet Asset Management (UK) sold 6,662 Medifast shares in Q2 2021, an estimated $1.81M.
  • Medifast made up 0.02% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #598 holding.
  • Pictet Asset Management (UK) first reported a position in Medifast in Q1 2019 and has held it in 10 quarters since.
  • Pictet Asset Management (UK)'s Medifast position peaked at $43.1M in Q4 2019.
  • 301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.